——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– New Products/molecular diagnostics 09.12.2011 Berlin, Germany, December 9, 2011 – Epigenomics AG (ISIN: DE000A1K0516) reports the completion of the clinical validation study [...]
Tag Archive > Colonoscopy
EANS-News: Epigenomics AG Completes U.S. Clinical Validation Study for Colorectal Cancer Blood Test Epi proColon; Provides Update on U.S. Regulatory Plans
——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/New Products/molecular diagnostics Subtitle: Conference Call Scheduled for today, 9thDecember 2011 at 4 pm CET Berlin, Germany, and Seattle, WA, U.S.A., December 9, 2011 (euro adhoc) – Epigenomics AG (Frankfurt Prime Standard: ECX), the cancer [...]
EANS-News: Epigenomics AG reports EpiproColon® 2.0 finds 95% of cancers in clinical study
——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/New Products/molecular diagnostics Subtitle: Study provides clinical evidence for CE-marking in Europe and paves way to US pivotal clinical trial for submission to FDA before year-end Berlin, Germany, and Seattle, WA, USA, September 19, 2011 [...]
EANS-News: Epigenomics Signs Distribution Deal with DATEKS for Epi proColon in Turkey
Second distributor to be signed-up for Epi proColon – more expected to come shortly ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/Molecular diagnostics Subtitle: Second distributor to be signed-up for Epi proColon – more expected to come shortly BERLIN and SEATTLE, October [...]
EANS-News: Epigenomics AG: New Clinical Data for Septin9 Colorectal Cancer Blood Test Presented at UEGW
Independent validation of laboratory test used in PRESEPT Study shows that the test finds 86% of the cancers ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/Molecular diagnostics Subtitle: Independent validation of laboratory test used in PRESEPT Study shows that the test finds [...]
EANS-Adhoc: Ad Hoc Announcement pursuant to para 15 WpHG (German Securities Trading Act) Epigenomics AG: Licensee ARUP Laboratories Launches Septin9 Colorectal Cancer Blood Test in the United States
——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– New Products/Molecular diagnostics 20.07.2010 Berlin and Seattle, July 20, 2010 – Epigenomics AG (ISIN: DE000A0BVT96) reports that its licensee ARUP Laboratories, Salt [...]
EANS-News: Epigenomics AG: Laboratory Network synlab Now Offering Septin9 Testing
European diagnostic laboratory network synlab has started offering Septin9 blood testing through its 55 German sites synlab to measure Septin9 using Epi proColon kit on Applied Biosystems 7500 Fast Real-time PCR System; CE-marked kit now also validated for this instrument ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content [...]
EANS-News: Epigenomics AG: PRESEPT Study Subject Enrollment Successfully Completed
7,852 subjects prospectively enrolled including more than 50 cancer cases Blood samples selected for testing by independent biostatistics group Septin9 testing in three independent laboratories on track; majority of samples tested Completion of PRESEPT Study and reporting of top-line results expected for early 2010 ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely [...]
EANS-News: Novel German Research Alliance to Detect Precursors of Colorectal Cancer – Munich Technical University, Epigenomics AG and KVB to develop novel approaches to cancer prevention
——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– research/new product/molecular diagnostics Berlin and Munich, Germany, May 26, 2009 (euro adhoc) – The German Federal Ministry of Education and Research will fund a clinical research project for the early detection of colorectal cancer, to be [...]